Vertex Pharmaceuticals (NasdaqGS:VRTX) is reassessing its pain management program after disappointing FDA label discussions ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is among the most profitable healthcare stocks to buy. On January 26, UBS ...

China-based biologics CDMO WuXi Biologics (HKEX: 2269) has signed a license and research services agreement with US biotech Vertex Pharmaceuticals (Nasdaq: VRTX) covering a preclinical trispecific ...

Reporting season for the December quarter has come to an end, and these five ASX-listed gold developers are making big ...

CRISPR Therapeutics heads into Q4 earnings with rising Casgevy sales, collaboration revenues from Vertex, and a history of beating estimates.

Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior ...

Description: Honey finds coupons with one click. Thanks to Honey for sponsoring! Keyboard build (affiliate links below) ...

Pro and Ultra subscribers now get monthly Google Cloud credits, part of an end to end build to deploy workflow.

Detailed price information for Satellos Bioscience Inc (MSCLF) from The Globe and Mail including charting and trades.

Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...

Google Cloud partner 66degrees explains Gemini Enterprise customer wins, data and AI services growth, Google innovation and ...

Miles Andrews, BSc (Hons), BMBS (Hons), FRACP, PhD, Medical Oncologist and Senior Research Fellow at the Alfred Hospital and Monash University, Melbourne, Australia; co-author of the NADINA study.